277 related articles for article (PubMed ID: 16696194)
1. Microbial identification strategies in the pharmaceutical industry.
Cundell AM
PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
[TBL] [Abstract][Full Text] [Related]
2. Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination.
Moldenhauer J
PDA J Pharm Sci Technol; 2006; 60(2):81-8. PubMed ID: 16696190
[No Abstract] [Full Text] [Related]
3. Managing the microbiological quality of pharmaceutical excipients.
Cundell AM
PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
[TBL] [Abstract][Full Text] [Related]
4. Introduction to papers on mycoplasmology presented at a Parenteral Drug Association mycoplasma workshop.
Potts BJ
Biologicals; 2010 Mar; 38(2):181-2. PubMed ID: 20079662
[No Abstract] [Full Text] [Related]
5. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
Hasanain F; Guenther K; Mullett WM; Craven E
PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
[TBL] [Abstract][Full Text] [Related]
6. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
Shintani H
Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
[TBL] [Abstract][Full Text] [Related]
7. Top ten hot topics in parenteral science and technology.
Akers MJ; Nail SL; Saffell-Clemmer W
PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
[TBL] [Abstract][Full Text] [Related]
8. FDA's aseptic processing: proposed regulation.
Barr DB
J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
[No Abstract] [Full Text] [Related]
9. Charting and Evaluation of Environmental Microbial Monitoring Data.
Bar R
PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105
[TBL] [Abstract][Full Text] [Related]
10. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
[TBL] [Abstract][Full Text] [Related]
11. Validation Studies for Microbial Contamination and Control of Contaminants.
Shintani H
Biocontrol Sci; 2015; 20(3):161-70. PubMed ID: 26412695
[TBL] [Abstract][Full Text] [Related]
12. [Microbiological in-process control in drug manufacture].
Seyfarth VH
Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
[TBL] [Abstract][Full Text] [Related]
13. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
[TBL] [Abstract][Full Text] [Related]
14. The production of fine chemicals by biotransformations.
Straathof AJ; Panke S; Schmid A
Curr Opin Biotechnol; 2002 Dec; 13(6):548-56. PubMed ID: 12482513
[TBL] [Abstract][Full Text] [Related]
15. Organic solvents in the pharmaceutical industry.
Grodowska K; Parczewski A
Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
[TBL] [Abstract][Full Text] [Related]
16. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
17. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.
Tidswell EC; Tirumalai RS; Gross DD
PDA J Pharm Sci Technol; 2024 Jun; 78(3):348-357. PubMed ID: 38942475
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different incubation conditions for microbiological environmental monitoring.
Gordon O; Berchtold M; Staerk A; Roesti D
PDA J Pharm Sci Technol; 2014; 68(5):394-406. PubMed ID: 25336415
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Particulate Matter in Liquid-Finished Dosage Forms.
Duchek J; Havasi B
PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
